PCM
PFE icon

Pennant Capital Management’s Pfizer PFE Stock Holding History

Pennant Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,190,500
Closed -$97.7M – 42
2015
Q4 		$97.7M Buy
+3,190,500
New +$100M 2.49% 24

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Pennant Capital Management's PFE Position: Q1 2016 in Review

Pennant Capital Management sold out of Pfizer (PFE) in Q1 2016, closing a stake of 3,190,500 shares — an estimated $97.7M sold.

Pennant Capital Management first reported a position in PFE in Q4 2015 and held it in 1 quarter. The position peaked at $97.7M in Q4 2015. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

  • Pennant Capital Management reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
  • Pennant Capital Management sold 3,190,500 Pfizer shares in Q1 2016, an estimated $97.7M.
  • Pennant Capital Management first reported a position in Pfizer in Q4 2015 and held it in 1 quarter.
  • Pennant Capital Management's Pfizer position peaked at $97.7M in Q4 2015.
  • 1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Pennant Capital Management's 13F filing for Q1 2016, filed 16 May 2016.